Skip to main content
OpenTrials
Completed

NCT Number: NCT03913936

Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention Pilot

This research study is piloting a new internet-based research tool (YES portal). The main purpose of this pilot study is to test the web-based interface.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–44 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Dana Farber Cancer Institute

Boston, Massachusetts, 02215, United States

About this study

This study is being done to pilot a web-based research intervention tool. The investigators hope that by piloting it with the participants they can improve the tool and the other processes. The main purpose of this pilot study is to test the web-based interface, the participant's engagement with the platform, and the recruitment procedures. This initial pilot study will inform the design of a larger study intended to monitor common symptoms and behavior, and to provide supportive care information and research opportunities in an iterative manner for young women who have been diagnosed with breast cancer using the YES portal, built for smartphones, tablets, and computers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Between the ages of 18-44 years
  • A history of breast cancer; we will pilot in 3 separate cohorts consisting of 10 patients each: newly diagnosed patients receiving care at DFCI, prevalent survivors who have completed early active therapy (surgery, chemotherapy and/or radiotherapy) and are being followed at DFCI, and women living with advanced breast cancer receiving care at DFCI
  • Be fluent in and able to read English
  • Have internet access on a regular basis at the time of consent that can support the web-based platform

Exclusion criteria

N/A

Treatment and study plan

YES portal

Other

The YES portal is designed to collect and assess participants' toxicities and symptoms, as well as informational needs in between visits with their clinician

Primary outcomes

  1. Frequency of logging into the portal.

    Time frame: 2 years

    To measure the number of times participants engage with the portal using log in data collected from back-end of portal.

  2. Time spent in the portal.

    Time frame: 2 years

    To summarize the number of hours/minutes the participant spent using portal through data collected from back-end of portal.

  3. Time spent responding the survey.

    Time frame: 2 years

    To summarize the number of hours/minutes the survey takes to complete through data collected from back-end of portal.

  4. Frequency of information downloads.

    Time frame: 2 years

    To measure the number of times participants download the resource sources provided through data collected from back-end of portal.

  5. Participant-reported utility of the portal.

    Time frame: 2 years

    Investigator developed questions will be used to assess the utility of the portal including the perceived usefulness of portal in addressing symptoms and needs and ease of use.

  6. Participant-reported recommendations for improving the portal.

    Time frame: 2 years

    Investigator developed questions asking participants for feedback pertaining to ways to improve the portal and processes.

Sponsors and collaborators

Lead sponsor

Dana-Farber Cancer Institute

Other

Collaborators

  • Breast Cancer Research Foundation

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Apr 12, 2019
Registry last updated
Apr 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.